Daniel E. Geffken - Insider Trading & Ownership

Entity
Individual
Location
Damonmill Square, Suite 6 A, Concord, Massachusetts
Summary
The estimated net worth of Daniel E. Geffken is at least $138K dollars as of May 20, 2024. Daniel E. Geffken is the Chief Financial Officer of PHOENIX BIOTECH ACQUISITION CORP. and owns shares of CERO THERAPEUTICS HOLDINGS, INC. (CERO) stock worth about $100K. Daniel E. Geffken is the INTERIM CFO of Eloxx Pharmaceuticals, Inc. and owns shares of Eloxx Pharmaceuticals, Inc. (ELOX) stock worth about $36K. Daniel E. Geffken is the Director of WINDTREE THERAPEUTICS INC /DE/ and owns shares of WINDTREE THERAPEUTICS INC /DE/ (WINT) stock worth about $2.22K.
All Insider Reports
All Insider Reports

Ownership of Daniel E. Geffken

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CERO, CEROW CERO THERAPEUTICS HOLDINGS, INC. Chief Financial Officer $100K Feb 14, 2024
ELOX Eloxx Pharmaceuticals, Inc. Interim Cfo $36K Nov 29, 2021
WINT, WINTW WINDTREE THERAPEUTICS INC /DE/ Director $2.22K Aug 23, 2023
CALC CalciMedica, Inc. Interim CFO May 17, 2024
PMN ProMIS Neurosciences Inc. Chief Financial Officer Oct 26, 2023

Insider Transactions Reported by Daniel E. Geffken:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.